Todays Report: The West Coast Financial LLC decides to keep it stake in Walgreens Boots Alliance Inc. (WBA) to the level of $7,232,000

The West Coast Financial LLC decides to keep it stake in Walgreens Boots Alliance Inc. (WBA) to the level of $7,232,000

West Coast Financial LLC boosted its position in Walgreens Boots Alliance Inc. (NASDAQ:WBA) by 0.4% during the second quarter, Holdings Channel reports. The institutional investor owned 86,854 shares of the pharmacy operator’s stock after buying an additional 364 shares during the period. Walgreens Boots Alliance makes up approximately 2.6% of West Coast Financial LLC’s portfolio, making the stock its 5th largest position. West Coast Financial LLC’s holdings in Walgreens Boots Alliance were worth $7,232,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. First Citizens Bank & Trust Co. increased its position in Walgreens Boots Alliance by 0.9% in the second quarter. First Citizens Bank & Trust Co. now owns 2,470 shares of the pharmacy operator’s stock worth $206,000 after buying an additional 21 shares in the last quarter. Signaturefd LLC increased its position in Walgreens Boots Alliance by 2.7% in the second quarter. Signaturefd LLC now owns 1,802 shares of the pharmacy operator’s stock worth $150,000 after buying an additional 48 shares in the last quarter. Brookstone Capital Management increased its position in Walgreens Boots Alliance by 0.3% in the second quarter. Brookstone Capital Management now owns 17,077 shares of the pharmacy operator’s stock worth $1,422,000 after buying an additional 52 shares in the last quarter. SignalPoint Asset Management LLC increased its position in Walgreens Boots Alliance by 1.0% in the second quarter. SignalPoint Asset Management LLC now owns 5,964 shares of the pharmacy operator’s stock worth $497,000 after buying an additional 59 shares in the last quarter. Finally, MAI Capital Management increased its position in Walgreens Boots Alliance by 0.8% in the second quarter. MAI Capital Management now owns 8,136 shares of the pharmacy operator’s stock worth $677,000 after buying an additional 61 shares in the last quarter. Hedge funds and other institutional investors own 59.76% of the company’s stock.

Shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded down 1.29% during mid-day trading on Friday, reaching $81.10. The company had a trading volume of 7,971,224 shares. The firm’s 50-day moving average price is $80.61 and its 200 day moving average price is $80.85. Walgreens Boots Alliance Inc. has a 52-week low of $71.50 and a 52-week high of $89.15. The company has a market cap of $87854.25 billion, a price-to-earnings ratio of 21.23 and a beta of 1.01.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, October 20th. The pharmacy operator reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $0.99 by $0.08. Walgreens Boots Alliance had a return on equity of 16.33% and a net margin of 3.56%. The firm had revenue of $28.60 billion for the quarter, compared to analyst estimates of $29.06 billion. During the same period in the prior year, the firm posted $0.88 EPS. The company’s revenue for the quarter was up .4% on a year-over-year basis. Equities analysts expect that Walgreens Boots Alliance Inc. will post $5.02 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, December 12th. Stockholders of record on Thursday, November 17th will be given a dividend of $0.375 per share. The ex-dividend date of this dividend is Tuesday, November 15th. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.85%. Walgreens Boots Alliance’s payout ratio is 39.27%.

Several equities analysts have commented on WBA shares. Jefferies Group set a $95.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Sunday, October 23rd. Evercore ISI reiterated a “buy” rating and set a $93.00 price target on shares of Walgreens Boots Alliance in a report on Thursday, July 7th. JPMorgan Chase & Co. reiterated a “buy” rating on shares of Walgreens Boots Alliance in a report on Thursday, July 7th. Barclays PLC increased their price target on Walgreens Boots Alliance from $76.00 to $79.00 and gave the company an “equal weight” rating in a report on Thursday, July 7th. Finally, Bank of America Corp. reiterated a “buy” rating and set a $94.00 price target on shares of Walgreens Boots Alliance in a report on Tuesday, August 30th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of “Buy” and a consensus price target of $91.35.

In other news, EVP Kathleen Wilson-Thompson sold 23,996 shares of the company’s stock in a transaction on Thursday, September 8th. The stock was sold at an average price of $85.00, for a total transaction of $2,039,660.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 21.10% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Related posts

Leave a Comment